Long-Lasting Relief, One Shot at a Time. #LongActingInjectables #PharmaInnovation #DrugDelivery #PharmaceuticalResearch #Biopharma #MedicalTechnology #DrugDevelopment #IndianPharma #HealthcareInnovation #ClinicalResearch #SustainedRelease #unitedbiotechindia

Long-Acting Injectable Agents Continue to Reshape the HIV Care Continuum https://t.co/JqIQ03RIoh #LongActingInjectables #LongActingAgents #HIV

In case you missed our latest blog, "Long-Acting Injectable Agents Continue to Reshape the HIV Care Continuum" https://t.co/JqIQ03RIoh #LongActingInjectables #LongActingAgents #HIV

"Eliminating HIV has required and will continue to require multiple tools of treatment. Current utilization of LAIs will lead to the development of new injectables and non-injectable long-acting agents." Read more: https://t.co/JqIQ03RIoh #LongActingInjectables #LongActingAgents

"Cabenuva (cabotegravir plus rilpivirine), approved in January 2021, is the first and only complete long-acting injectable and two-drug regimen available for HIV treatment." Read more: https://t.co/JqIQ03RIoh #LongActingInjectables #LongActingAgents #HIV

New video series from Dr. Mauricio Tohen: How to present long-acting injectables for bipolar I patients.  https://t.co/jXLhYVu974 #hottopic #bipolardisorder #longactinginjectables #PsychU

New video series from Dr. Mauricio Tohen: How does long-acting injectable affect adherence to other meds in bipolar I?  #hottopic #bipolardisorder #adherence #longactinginjectables #psychu  https://t.co/BTsuTbzW7H

Hot Topic: Long-Acting Injectables for Bipolar Disorder  Dr. Mauricio Tohen discusses the evidence on whether long-acting injectables can prevent relapse in bipolar I.  https://t.co/OCvTKdhjGr #bipolardisorder #longactinginjectables #relapseprevention #hottopic #PsychU

The @UNNamibia Country Team (UNCT) bade farewell to lovely colleague and member of the @UnaidsNamibia Joint Team, Dr Mary Nana Brantuo of @WHONAMIBIA. The UN Resident Coordinator Ms @hphororo presented a gift to Mary on behalf of the UNCT. #longactinginjectables Farewell Mary!

Какво знаем за най-новата ХИВ терапия с рекордната ефикасност от 6 месеца? Прочети тук: https://t.co/TAZVpV4QYm #lenacapavir #longactinginjectables #Europe #EuropeanUnion #europeancommission #ленакапавир #HIV #ХИВ #ХИВтерапия

🧵 Battle for HIV PrEP Market: Gilead's Twice-Yearly Injection Challenges GSK's Apretude #HivPrevention #Prep #Lenacapavir #Apretude #LongActingInjectables #GileadSciences #Gsk #ViivHealthcare

Are you HIV-negative & residing in the United States? @adapadvocacy wants to hear from YOU! Please take just a few minutes to complete their Perspectives Survey on Long-Acting Injectable (LAI) #HIV Prevention (#PrEP): https://t.co/yhk6WaUQXZ #LongActingInjectables #Patients

📢#WEBINAR: Learn about Long-Acting Injectables for #HIV with ITPC Global! Explore ARV basics, learn about long-acting options & gain insights from community perspectives. 📅Thurs 15 Feb⌚3-5 PM (GMT+2) Register here 👉🏽 https://t.co/409AX42YPN #LongActingInjectables

Global HIV market to cross $32 billion in 7 major markets in 2033: Report    https://t.co/CSGGF1cjnN #HIVTreatment #Lenacapavir #HIVPrevention #GileadSciences #GlobalDataReport #LongActingInjectables #HIVMarket #MedicalInnovation #HIVCare #PrEP

What an informative session from @JNJNews on other treatment options for people living with #HIV. #longactinginjectables #INTERESTconf Thank you!

UZEDY wins FDA nod for Bipolar I maintenance therapy, boosting Teva and Medincell’s psychiatric drug portfolio https://t.co/7tIoxbNcgZ #BipolarIDisorder #FDAApproval #UZEDY #Teva #Medincell #Psychiatry #MentalHealth #LongActingInjectables

Injectable PrEP a Game Changer for HIV Prevention, But is it Accessible? https://t.co/wXQ2A9cZut #LongActingInjectables #InjectablePrEP #PrEP #HIV #Prevention

The injectable antiretroviral drug lenacapavir was safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a Phase 3 clinical trial. #lenacapavir #longactinginjectables #PrEP #Prevention #Women https://t.co/c7iSXAtjuf

Nearly a year into his experiment with long-acting injectables to manage his HIV, Matthew is already looking forward to formulations administered only twice a year. “I would welcome that with open arms,” he said. #LongActingInjectables #HIV https://t.co/xi3m7XZfMV

HIV LONG-ACTING INJECTABLES: Patient Access Considerations for Injectable HIV Therapies & Injectable HIV Pre-Exposure Prophylaxis https://t.co/TPAEjICGZC #HIV #TreatmentAsPrevention #PrEP #UequalsU #LongActingInjectables